| II-40 Pascal Chanu A model to predict progression free survival in patients with previously untreated HER2-positive progressive or recurrent locally advanced or metastatic breast cancer based on tumor growth inhibition metrics Wednesday 15:10-16:30 |
| II-40 Pascal Chanu A model to predict progression free survival in patients with previously untreated HER2-positive progressive or recurrent locally advanced or metastatic breast cancer based on tumor growth inhibition metrics Wednesday 15:10-16:30 |